Sintx Technologies Inc (SINT)

$1.96 +0.04 (2.08%)
Market Cap 8.29M
Revenue (ttm) 1.02M
Net Income (ttm) -10.36M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,015.69%
Debt to Equity Ratio 0.12
Volume 37,100
Avg Vol 57,464
Day's Range N/A - N/A
Shares Out 4.32M
Stochastic %K 7%
Beta 0.66
Analysts Sell
Price Target $11.00

Company Profile

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (P...

Industry: Medical Devices
Sector: Healthcare
Phone: 801 839 3500
Address:
1885 West 2100 South, Salt Lake City, United States
Boston7452
Boston7452 Jun. 24 at 6:00 PM
$SINT do you buy that Dr Bock stole trade secrets and gave them to Ned Medical without certain mgmt/board giving the ok?
1 · Reply
Boston7452
Boston7452 Jun. 24 at 5:25 PM
$SINT Si3N4 should be effective against Ebola, Hantavirus, & Bird Flus!
1 · Reply
Boston7452
Boston7452 Jun. 24 at 5:23 PM
$SINT Ebola detected in France after doctor tests positive following aid mission "A French doctor who was working in the Democratic Republic of the Congo (DRC) has tested positive for Ebola after returning home."
1 · Reply
amda
amda Jun. 24 at 3:58 PM
$SINT it's those tin foil hat people...
1 · Reply
amda
amda Jun. 24 at 3:58 PM
$SINT something weird happening....
0 · Reply
Boston7452
Boston7452 Jun. 23 at 7:39 PM
$SINT Buy Sintx stock, remove board and fire management, then auction the IP for many multiples current market cap. IP has 100s of billions in potential addressable markets.
0 · Reply
Boston7452
Boston7452 Jun. 23 at 7:37 PM
$SINT report to SEC & FBI. Mgmt/board think they can do whatever they want with Sintx IP, investors be damned. Snoopy is helping this.
0 · Reply
SnoopyDog
SnoopyDog Jun. 23 at 5:11 PM
$SINT Walking this s*** stock down where it belongs
0 · Reply
Boston7452
Boston7452 Jun. 22 at 5:03 PM
$SINT Bird flu is growing in numbers again and it’s just a matter of time before it can spread human to human. Ebola cases are also increasing. Hanta seems to be done for now. These are all viruses Sintx Si3N4 should be able to deactivate. Of course that design matter if Sintx mgmt continues to sit on the PPE tech.
1 · Reply
Boston7452
Boston7452 Jun. 22 at 4:49 PM
$SINT for Sinaptic to receive its warrant tranches, Sintx must recognize cumulative revenue of 2.5m which could be achievable this year. 5m, 10m, & 15m. This deal puts them on the path of achieving both 2.5m & 5m targets by some point in 2027. To reach 10 & 15m targets, Sintx needs to sell more ankle implants or sign more deals.
1 · Reply
Latest News on SINT
Sintx Technologies receives $3.2M in purchase orders

2026-06-22T14:00:56.000Z - 2 days ago

Sintx Technologies receives $3.2M in purchase orders

SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders

Jun 22, 2026, 9:00 AM EDT - 2 days ago

SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders

Sintx Technologies Transcript: Transcript

Jun 15, 2026, 11:13 AM EDT - 9 days ago

Sintx Technologies Transcript: Transcript

Sintx Technologies resumed with a Buy at Maxim

2026-06-04T11:45:10.000Z - 20 days ago

Sintx Technologies resumed with a Buy at Maxim

SINTX Technologies Announces Raise of Approximately $5.0 Million of Capital, Including a $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Jun 3, 2026, 9:00 AM EDT - 21 days ago

SINTX Technologies Announces Raise of Approximately $5.0 Million of Capital, Including a $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

SINTX Technologies to Present at the LD Micro Invitational XVI Conference

May 17, 2026, 3:30 PM EDT - 5 weeks ago

SINTX Technologies to Present at the LD Micro Invitational XVI Conference

Sintx Technologies initiated with a Buy at H.C. Wainwright

2026-04-13T10:11:23.000Z - 2 months ago

Sintx Technologies initiated with a Buy at H.C. Wainwright

SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution

Mar 23, 2026, 9:15 AM EDT - 3 months ago

SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution

Sintx Technologies announces first in-human surgery using FDA-cleared Sinaptic

2026-03-19T11:51:39.000Z - 3 months ago

Sintx Technologies announces first in-human surgery using FDA-cleared Sinaptic

SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant

Mar 19, 2026, 7:30 AM EDT - 3 months ago

SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant

Sintx Technologies appoints Elmore as President

2026-02-18T13:40:31.000Z - 4 months ago

Sintx Technologies appoints Elmore as President

SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms

Feb 18, 2026, 8:30 AM EST - 4 months ago

SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms

SINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4–5

Jan 29, 2026, 9:00 AM EST - 5 months ago

SINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4–5

Sintx Technologies signs supply agreement with EVONIK

2025-12-01T13:35:45.000Z - 7 months ago

Sintx Technologies signs supply agreement with EVONIK

SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

Dec 1, 2025, 8:30 AM EST - 7 months ago

SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

Sintx Technologies reports Q3 EPS ($3.46) vs ($6.96) last year

2025-11-13T13:05:19.000Z - 7 months ago

Sintx Technologies reports Q3 EPS ($3.46) vs ($6.96) last year

Sintx Technologies Earnings release: Q3 2025

Nov 13, 2025, 7:00 AM EST - 7 months ago

Sintx Technologies Earnings release: Q3 2025

Sintx Technologies announces launch of OsseoSculpt

2025-11-03T13:05:41.000Z - 8 months ago

Sintx Technologies announces launch of OsseoSculpt

SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System

Nov 3, 2025, 8:00 AM EST - 8 months ago

SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System

Sintx Technologies files to sell 1.74M shares of common stock for holders

2025-10-23T20:40:36.000Z - 8 months ago

Sintx Technologies files to sell 1.74M shares of common stock for holders

Sintx receives FDA clearance for SINAPTIC Foot, Ankle implant system

2025-10-20T11:05:38.000Z - 8 months ago

Sintx receives FDA clearance for SINAPTIC Foot, Ankle implant system

SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System

Oct 20, 2025, 7:00 AM EDT - 8 months ago

SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System

Sintx Technologies announces U.S. patent notice of allowance

2025-10-14T11:11:00.000Z - 9 months ago

Sintx Technologies announces U.S. patent notice of allowance

SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics

Oct 14, 2025, 7:00 AM EDT - 9 months ago

SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics

Sintx Technologies files to sell 541,450 shares of common stock for holders

2025-09-30T20:55:10.000Z - 9 months ago

Sintx Technologies files to sell 541,450 shares of common stock for holders

Why Is Sintx Technologies Stock (SINT) Down 20% Today?

2025-09-09T02:54:00.000Z - 10 months ago

Why Is Sintx Technologies Stock (SINT) Down 20% Today?

Sintx Technologies announces exercise of warrants for $3.8M gross proceeds

2025-09-08T12:01:04.000Z - 10 months ago

Sintx Technologies announces exercise of warrants for $3.8M gross proceeds

SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds

Sep 8, 2025, 7:54 AM EDT - 10 months ago

SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds

Sintx Technologies receives USPTO notice of allowance

2025-09-08T11:25:37.000Z - 10 months ago

Sintx Technologies receives USPTO notice of allowance

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

Sep 8, 2025, 7:00 AM EDT - 10 months ago

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

Sintx Technologies publishes study of antiviral activity of Silicon Nitride

2025-09-03T11:10:22.000Z - 10 months ago

Sintx Technologies publishes study of antiviral activity of Silicon Nitride

Sintx Technologies issues business update following strategic realignment

2025-08-15T11:11:47.000Z - 11 months ago

Sintx Technologies issues business update following strategic realignment

SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition

Aug 15, 2025, 7:00 AM EDT - 11 months ago

SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition

Sintx expands silicon nitride platform into hybrid CFR-PEKK trauma plates

2025-08-04T11:20:10.000Z - 11 months ago

Sintx expands silicon nitride platform into hybrid CFR-PEKK trauma plates

SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates

Aug 4, 2025, 7:00 AM EDT - 11 months ago

SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates

Sintx Technologies submits FDA 510k for silicon nitride foot, ankle devices

2025-07-22T11:10:59.000Z - 1 year ago

Sintx Technologies submits FDA 510k for silicon nitride foot, ankle devices

SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market

Jun 24, 2025, 8:30 AM EDT - 1 year ago

SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market

SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market

May 22, 2025, 7:00 AM EDT - 1 year ago

SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market

SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

May 15, 2025, 7:05 AM EDT - 1 year ago

SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

Sintx Technologies Earnings release: Q1 2025

May 15, 2025, 7:00 AM EDT - 1 year ago

Sintx Technologies Earnings release: Q1 2025

SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

Feb 26, 2025, 8:00 AM EST - 1 year ago

SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market

Feb 20, 2025, 6:15 AM EST - 1 year ago

SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market

SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Feb 19, 2025, 6:00 AM EST - 1 year ago

SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment

Nov 21, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

Nov 19, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

SINTX Technologies Announces Stock Repurchase Program

Nov 18, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Announces Stock Repurchase Program

SINTX Technologies Provides Positive Strategic Business Update for Q3 2024

Nov 14, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Provides Positive Strategic Business Update for Q3 2024

SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T

Oct 1, 2024, 8:00 AM EDT - 1 year ago

SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T

Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing”

Sep 20, 2024, 8:00 AM EDT - 1 year ago

Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing”

SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Sep 9, 2024, 8:00 AM EDT - 1 year ago

SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

SINTX Technologies to Explore Strategic Opportunities

Jun 18, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies to Explore Strategic Opportunities

SINTX Technologies Regains Compliance with Nasdaq Bid Price Requirement

Jun 12, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Regains Compliance with Nasdaq Bid Price Requirement

SINTX Technologies Receives Additional SBIR Contract for 3D Printing Technology

Jun 6, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Receives Additional SBIR Contract for 3D Printing Technology

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE MAY 28, 2024

May 23, 2024, 9:00 AM EDT - 2 years ago

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE MAY 28, 2024

SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT

Apr 29, 2024, 9:14 AM EDT - 2 years ago

SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT

SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock

Apr 3, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock

SINTX Technologies Announces Proposed Public Offering of Common Stock

Mar 29, 2024, 4:00 PM EDT - 2 years ago

SINTX Technologies Announces Proposed Public Offering of Common Stock

SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock

Mar 25, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock

SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET

Feb 21, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET

SINTX Technologies Announces Closing of $4.0 Million Public Offering

Feb 2, 2024, 2:33 PM EST - 2 years ago

SINTX Technologies Announces Closing of $4.0 Million Public Offering

SINTX Technologies Announces Pricing of $4.0 Million Public Offering

Jan 31, 2024, 9:20 AM EST - 2 years ago

SINTX Technologies Announces Pricing of $4.0 Million Public Offering

SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY

Jan 30, 2024, 4:01 PM EST - 2 years ago

SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY

SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE

Jan 23, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE

SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO

Jan 4, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO

SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS

Nov 7, 2023, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS

SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

Oct 11, 2023, 9:00 AM EDT - 2 years ago

SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

3DCERAM SINTO INC. and SINTX TECHNOLOGIES ANNOUNCE COLLABORATION TO DEVELOP MATERIALS AND TECHNOLOGIES FOR ADDITIVE MANUFACTURING OF ADVANCED CERAMICS

Aug 17, 2023, 9:00 AM EDT - 3 years ago

3DCERAM SINTO INC. and SINTX TECHNOLOGIES ANNOUNCE COLLABORATION TO DEVELOP MATERIALS AND TECHNOLOGIES FOR ADDITIVE MANUFACTURING OF ADVANCED CERAMICS

SINTX TECHNOLOGIES ANNOUNCES ITS NEW UTAH ARMOR FACILITY IS FULLY OPERATIONAL

Feb 14, 2023, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES ANNOUNCES ITS NEW UTAH ARMOR FACILITY IS FULLY OPERATIONAL

SINTX Technologies Announces Its New Utah Armor Facility Is Fully Operational

Feb 14, 2023, 9:00 AM EST - 3 years ago

SINTX Technologies Announces Its New Utah Armor Facility Is Fully Operational

SINTX Technologies Announces Closing of $12.0 Million Public Offering

Feb 10, 2023, 1:52 PM EST - 3 years ago

SINTX Technologies Announces Closing of $12.0 Million Public Offering

SINTX Technologies Announces Pricing of $12.0 Million Public Offering

Feb 7, 2023, 9:05 PM EST - 3 years ago

SINTX Technologies Announces Pricing of $12.0 Million Public Offering

SINTX Technologies Shares Select Preliminary Q4 2022 and Full Year 2022 Revenue Update

Jan 19, 2023, 9:00 AM EST - 3 years ago

SINTX Technologies Shares Select Preliminary Q4 2022 and Full Year 2022 Revenue Update

Boston7452
Boston7452 Jun. 24 at 6:00 PM
$SINT do you buy that Dr Bock stole trade secrets and gave them to Ned Medical without certain mgmt/board giving the ok?
1 · Reply
Boston7452
Boston7452 Jun. 24 at 5:25 PM
$SINT Si3N4 should be effective against Ebola, Hantavirus, & Bird Flus!
1 · Reply
Boston7452
Boston7452 Jun. 24 at 5:23 PM
$SINT Ebola detected in France after doctor tests positive following aid mission "A French doctor who was working in the Democratic Republic of the Congo (DRC) has tested positive for Ebola after returning home."
1 · Reply
amda
amda Jun. 24 at 3:58 PM
$SINT it's those tin foil hat people...
1 · Reply
amda
amda Jun. 24 at 3:58 PM
$SINT something weird happening....
0 · Reply
Boston7452
Boston7452 Jun. 23 at 7:39 PM
$SINT Buy Sintx stock, remove board and fire management, then auction the IP for many multiples current market cap. IP has 100s of billions in potential addressable markets.
0 · Reply
Boston7452
Boston7452 Jun. 23 at 7:37 PM
$SINT report to SEC & FBI. Mgmt/board think they can do whatever they want with Sintx IP, investors be damned. Snoopy is helping this.
0 · Reply
SnoopyDog
SnoopyDog Jun. 23 at 5:11 PM
$SINT Walking this s*** stock down where it belongs
0 · Reply
Boston7452
Boston7452 Jun. 22 at 5:03 PM
$SINT Bird flu is growing in numbers again and it’s just a matter of time before it can spread human to human. Ebola cases are also increasing. Hanta seems to be done for now. These are all viruses Sintx Si3N4 should be able to deactivate. Of course that design matter if Sintx mgmt continues to sit on the PPE tech.
1 · Reply
Boston7452
Boston7452 Jun. 22 at 4:49 PM
$SINT for Sinaptic to receive its warrant tranches, Sintx must recognize cumulative revenue of 2.5m which could be achievable this year. 5m, 10m, & 15m. This deal puts them on the path of achieving both 2.5m & 5m targets by some point in 2027. To reach 10 & 15m targets, Sintx needs to sell more ankle implants or sign more deals.
1 · Reply
Boston7452
Boston7452 Jun. 22 at 4:27 PM
$SINT if they actually recognize 2m of that revenue in a quarter they can force the b warrant conversion. Again if that happened. It’s definitely achievable.
0 · Reply
Boston7452
Boston7452 Jun. 22 at 3:40 PM
$SINT looks like they are trying to trigger the warrant tranches for Sinaptic. That requires actual revenue recognition.
0 · Reply
SnoopyDog
SnoopyDog Jun. 22 at 3:00 PM
$SINT No news would have been better lol
0 · Reply
focafoca99
focafoca99 Jun. 22 at 1:50 PM
$SINT captured over $3.2 million in new contract manufacturing purchase orders. https://www.rapidticker.com/news/sint-sintx-technologies-announces-receipt-of-0aae1b
0 · Reply
MrTicker
MrTicker Jun. 22 at 1:05 PM
$SINT SINTX Technologies Receives Purchase Orders From Multiple Contract Manufacturing Customers With Aggregate Value Exceeding $3.2M For Production Of Advanced Ceramic Components BENZINGA 8:03 AM ET 6/22/2026
0 · Reply
2TrustHim
2TrustHim Jun. 22 at 1:05 PM
$SINT Small Order Good Start???
0 · Reply
SPARTANVI
SPARTANVI Jun. 22 at 1:02 PM
$WNW Same setup as $NXTS $SINT just much smaller float 🔥⏰️👀
0 · Reply
Stock_Catcher
Stock_Catcher Jun. 22 at 1:00 PM
$SINT SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders
0 · Reply
Boston7452
Boston7452 Jun. 22 at 12:06 AM
$SINT and Ned Medical are supposed to be partners with Varian Medical taking a stake in what they were jointly creating valuing Ned Medical at 30-40m best guess. Ned Medical cannot manufacture this technology without Sintx unless its former CTO Ryan Bock gave Ned Medical that know how. Yet Sintx is only suing Dr Bock and not trying to stop Ned Medical from manufacturing the Combisphere beads it developed for Ned Medical out of its proprietary material. Sintx also has not disclosed this information publicly which should be a SEC violation. I found out about this simply by chance when research caused the lawsuit to appear in a google search. https://www.pacermonitor.com/public/case/63801444/SINTX_Technologies,_Inc_v_Bock
1 · Reply
Boston7452
Boston7452 Jun. 18 at 6:26 PM
$SINT if I’m right about the conspiracy those same investors will profit investing in Ned Medical so you can see why they wouldn’t care about mgmt/board stealing IP from Sintx. Also why FBI needs to be involved to investigate this conspiracy.
0 · Reply
SnoopyDog
SnoopyDog Jun. 18 at 6:22 PM
$SINT ouch
0 · Reply
Boston7452
Boston7452 Jun. 18 at 3:44 PM
$SINT owning shares is how you can vote to remove the board. Buying them is how you can own them. Truth is though the only real way to stop mgmt is to get the SEC involved because majority shareholders will allow mgmt to get away with IP theft.
0 · Reply